Due to EphA2 overexpression in many types of cancers, as explained in Section 3, the process of ligand induced receptor endocytosis and the consequent degradation have been widely analyzed as potential routes to reduce tumor malignancy. This evidence concerns the gene EPHA2 and cancer.